Want bold action? Hire a pharma-oriented narcissist, study finds

Which pharma CEOs are most likely to make bold moves when faced with big challenges? Narcissists. If media attention runs high, narcissistic execs will attack problems aggressively by embracing disruptive technologies, a Harvard Business Review study of the industry found. Report | Abstract

Suggested Articles

UnitedHealthcare will stop covering Descovy in PrEP in favor of Truvada, which is on track to see low-cost generic competition in September.

AstraZeneca has signed into the EU’s first finalized COVID-19 vaccine supply agreement.  

The U.K.'s two new deals with J&J and Novavax bring its stockpile of potential COVID-19 vaccines to 340 million doses while expanding clinical trials.